S&P 500   4,452.12 (-0.08%)
DOW   34,960.28 (+0.47%)
QQQ   371.04 (-0.61%)
AAPL   145.25 (-1.14%)
MSFT   295.26 (-1.37%)
FB   351.22 (-0.49%)
GOOGL   2,826.63 (-0.62%)
TSLA   788.67 (+1.84%)
AMZN   3,363.66 (-1.81%)
NVDA   216.32 (-2.03%)
BABA   147.25 (+1.50%)
NIO   35.95 (+1.61%)
CGC   14.46 (+3.95%)
GE   105.65 (+1.78%)
MU   75.20 (+1.55%)
AMD   107.39 (+1.50%)
T   27.60 (+1.73%)
F   14.12 (+2.47%)
ACB   6.16 (+3.53%)
DIS   178.37 (+1.35%)
PFE   44.04 (+0.23%)
BA   226.21 (+2.18%)
BAC   43.17 (+2.44%)
S&P 500   4,452.12 (-0.08%)
DOW   34,960.28 (+0.47%)
QQQ   371.04 (-0.61%)
AAPL   145.25 (-1.14%)
MSFT   295.26 (-1.37%)
FB   351.22 (-0.49%)
GOOGL   2,826.63 (-0.62%)
TSLA   788.67 (+1.84%)
AMZN   3,363.66 (-1.81%)
NVDA   216.32 (-2.03%)
BABA   147.25 (+1.50%)
NIO   35.95 (+1.61%)
CGC   14.46 (+3.95%)
GE   105.65 (+1.78%)
MU   75.20 (+1.55%)
AMD   107.39 (+1.50%)
T   27.60 (+1.73%)
F   14.12 (+2.47%)
ACB   6.16 (+3.53%)
DIS   178.37 (+1.35%)
PFE   44.04 (+0.23%)
BA   226.21 (+2.18%)
BAC   43.17 (+2.44%)
S&P 500   4,452.12 (-0.08%)
DOW   34,960.28 (+0.47%)
QQQ   371.04 (-0.61%)
AAPL   145.25 (-1.14%)
MSFT   295.26 (-1.37%)
FB   351.22 (-0.49%)
GOOGL   2,826.63 (-0.62%)
TSLA   788.67 (+1.84%)
AMZN   3,363.66 (-1.81%)
NVDA   216.32 (-2.03%)
BABA   147.25 (+1.50%)
NIO   35.95 (+1.61%)
CGC   14.46 (+3.95%)
GE   105.65 (+1.78%)
MU   75.20 (+1.55%)
AMD   107.39 (+1.50%)
T   27.60 (+1.73%)
F   14.12 (+2.47%)
ACB   6.16 (+3.53%)
DIS   178.37 (+1.35%)
PFE   44.04 (+0.23%)
BA   226.21 (+2.18%)
BAC   43.17 (+2.44%)
S&P 500   4,452.12 (-0.08%)
DOW   34,960.28 (+0.47%)
QQQ   371.04 (-0.61%)
AAPL   145.25 (-1.14%)
MSFT   295.26 (-1.37%)
FB   351.22 (-0.49%)
GOOGL   2,826.63 (-0.62%)
TSLA   788.67 (+1.84%)
AMZN   3,363.66 (-1.81%)
NVDA   216.32 (-2.03%)
BABA   147.25 (+1.50%)
NIO   35.95 (+1.61%)
CGC   14.46 (+3.95%)
GE   105.65 (+1.78%)
MU   75.20 (+1.55%)
AMD   107.39 (+1.50%)
T   27.60 (+1.73%)
F   14.12 (+2.47%)
ACB   6.16 (+3.53%)
DIS   178.37 (+1.35%)
PFE   44.04 (+0.23%)
BA   226.21 (+2.18%)
BAC   43.17 (+2.44%)
NYSE:HLI

Houlihan Lokey Stock Forecast, Price & News

$95.80
+0.43 (+0.45 %)
(As of 09/27/2021 11:10 AM ET)
Add
Compare
Today's Range
$95.18
$96.17
50-Day Range
$80.28
$95.37
52-Week Range
$55.25
$95.64
Volume1,895 shs
Average Volume348,312 shs
Market Capitalization$6.55 billion
P/E Ratio18.78
Dividend Yield1.80%
Beta0.68
30 days | 90 days | 365 days | Advanced Chart
Receive HLI News and Ratings via Email

Sign-up to receive the latest news and ratings for Houlihan Lokey and its competitors with MarketBeat's FREE daily newsletter.


Houlihan Lokey logo

About Houlihan Lokey

Houlihan Lokey, Inc. engages in the provision of investment banking services. It operates through the following segments: Corporate Finance, Financial Restructuring and Financial and Valuation Advisory. The Corporate Finance segment provides general financial advisory services in addition to advice on mergers and acquisitions and capital markets offering. The Financial Restructuring segment provides advice to debtors, Creditors and parties-in-interest in connection with recapitalization or deleveraging transactions. The Financial Valuation and Advisory Services segment provides valuation of various assets including companies, illiquid debt and equity Securities and intellectual property. The company was founded in 1972 and is headquartered in Los Angeles, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.65 out of 5 stars

Finance Sector

145th out of 1,330 stocks

Investment Advice Industry

13th out of 60 stocks

Analyst Opinion: 0.8Community Rank: 4.4Dividend Strength: 2.5Insider Behavior: 5.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Houlihan Lokey (NYSE:HLI) Frequently Asked Questions

Is Houlihan Lokey a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Houlihan Lokey in the last twelve months. There are currently 3 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Houlihan Lokey stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLI, but not buy additional shares or sell existing shares.
View analyst ratings for Houlihan Lokey
or view top-rated stocks.

What stocks does MarketBeat like better than Houlihan Lokey?

Wall Street analysts have given Houlihan Lokey a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Houlihan Lokey wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Houlihan Lokey's next earnings date?

Houlihan Lokey is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Houlihan Lokey
.

How were Houlihan Lokey's earnings last quarter?

Houlihan Lokey, Inc. (NYSE:HLI) announced its quarterly earnings data on Tuesday, August, 3rd. The financial services provider reported $1.19 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.12 by $0.07. The financial services provider earned $372.70 million during the quarter, compared to the consensus estimate of $380.84 million. Houlihan Lokey had a net margin of 20.90% and a trailing twelve-month return on equity of 26.92%. The company's revenue for the quarter was up 76.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.56 earnings per share.
View Houlihan Lokey's earnings history
.

How has Houlihan Lokey's stock been impacted by COVID-19 (Coronavirus)?

Houlihan Lokey's stock was trading at $48.92 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HLI stock has increased by 95.4% and is now trading at $95.58.
View which stocks have been most impacted by COVID-19
.

How often does Houlihan Lokey pay dividends? What is the dividend yield for Houlihan Lokey?

Houlihan Lokey announced a quarterly dividend on Tuesday, August 3rd. Stockholders of record on Thursday, September 2nd will be paid a dividend of $0.43 per share on Wednesday, September 15th. This represents a $1.72 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend is Wednesday, September 1st.
View Houlihan Lokey's dividend history
.

Is Houlihan Lokey a good dividend stock?

Houlihan Lokey pays an annual dividend of $1.72 per share and currently has a dividend yield of 1.80%. Houlihan Lokey has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Houlihan Lokey is 37.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Houlihan Lokey will have a dividend payout ratio of 37.97% next year. This indicates that Houlihan Lokey will be able to sustain or increase its dividend.
View Houlihan Lokey's dividend history.

What price target have analysts set for HLI?

6 analysts have issued 1 year target prices for Houlihan Lokey's stock. Their forecasts range from $60.00 to $80.00. On average, they anticipate Houlihan Lokey's share price to reach $70.60 in the next twelve months. This suggests that the stock has a possible downside of 26.1%.
View analysts' price targets for Houlihan Lokey
or view top-rated stocks among Wall Street analysts.

Who are Houlihan Lokey's key executives?

Houlihan Lokey's management team includes the following people:
  • Scott Lee Beiser, Chief Executive Officer & Director
  • Scott Joseph Adelson, Co-President & Director
  • David Abraham Preiser, Co-President, Director & Senior Managing Director
  • J. Lindsey Alley, Chief Financial Officer
  • Charles A. Yamarone, Chief Corporate Governance & Compliance Officer

What is Scott Beiser's approval rating as Houlihan Lokey's CEO?

77 employees have rated Houlihan Lokey CEO Scott Beiser on Glassdoor.com. Scott Beiser has an approval rating of 87% among Houlihan Lokey's employees.

What other stocks do shareholders of Houlihan Lokey own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Houlihan Lokey investors own include Energy Transfer (ET), AT&T (T), CVS Health (CVS), The Home Depot (HD), Honeywell International (HON), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Alibaba Group (BABA) and Cisco Systems (CSCO).

When did Houlihan Lokey IPO?

(HLI) raised $301 million in an initial public offering (IPO) on Thursday, August 13th 2015. The company issued 13,100,000 shares at $22.00-$24.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and UBS Investment Bank, Keefe, Bruyette & Woods (A Stifel Company), Houlihan Lokey, Sandler O'Neill + Partners and JMP Securities were co-managers.

What is Houlihan Lokey's stock symbol?

Houlihan Lokey trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLI."

Who are Houlihan Lokey's major shareholders?

Houlihan Lokey's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.50%), BlackRock Inc. (6.43%), Kayne Anderson Rudnick Investment Management LLC (5.18%), Van Berkom & Associates Inc. (2.20%), Neuberger Berman Group LLC (2.10%) and Price T Rowe Associates Inc. MD (2.09%). Company insiders that own Houlihan Lokey stock include Christopher M Crain, David A Preiser, Irwin Gold, J Lindsey Alley, Robert A Schriesheim, Scott Joseph Adelson and Scott L Beiser.
View institutional ownership trends for Houlihan Lokey
.

Which major investors are selling Houlihan Lokey stock?

HLI stock was sold by a variety of institutional investors in the last quarter, including Van Berkom & Associates Inc., BlackRock Inc., First Trust Advisors LP, Wells Fargo & Company MN, FMR LLC, Neuberger Berman Group LLC, Citigroup Inc., and Tudor Investment Corp Et Al. Company insiders that have sold Houlihan Lokey company stock in the last year include Irwin Gold, and Scott Joseph Adelson.
View insider buying and selling activity for Houlihan Lokey
or view top insider-selling stocks.

Which major investors are buying Houlihan Lokey stock?

HLI stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Thrivent Financial for Lutherans, Thrivent Financial for Lutherans, Millennium Management LLC, Clearbridge Investments LLC, M&G Investment Management Ltd., Renaissance Technologies LLC, and Artemis Investment Management LLP.
View insider buying and selling activity for Houlihan Lokey
or or view top insider-buying stocks.

How do I buy shares of Houlihan Lokey?

Shares of HLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Houlihan Lokey's stock price today?

One share of HLI stock can currently be purchased for approximately $95.58.

How much money does Houlihan Lokey make?

Houlihan Lokey has a market capitalization of $6.53 billion and generates $1.53 billion in revenue each year. The financial services provider earns $312.77 million in net income (profit) each year or $4.62 on an earnings per share basis.

How many employees does Houlihan Lokey have?

Houlihan Lokey employs 1,574 workers across the globe.

What is Houlihan Lokey's official website?

The official website for Houlihan Lokey is www.hl.com.

Where are Houlihan Lokey's headquarters?

How can I contact Houlihan Lokey?

Houlihan Lokey's mailing address is 10250 CONSTELLATION BLVD. 5TH FLOOR, LOS ANGELES CA, 90067. The financial services provider can be reached via phone at (310) 788-5200 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.